(Copy) Publications

Latest publication

Banks et al
Birth Defects Research, 2023

Preclinical development of a novel Group B Streptococcus (GBS) vaccine candidate for maternal immunization based upon the alpha-like protein family of GBS surface proteins (Alp).

More publications

Dangor et al
Vaccine, 2023

Association of infant Rib and Alp1 surface protein N-terminal domain immunoglobulin G and invasive Group B Streptococcal disease in young infants.

Gonzalez-Miro et al
iScience, 2023

Safety and immunogenicity of the group B streptococcus vaccine AlpN in a placebo-controlled double-blind phase 1 trial.

Dominguez et Randis
Cell Reports Medicine (Commentary), 2022

Toward the development of a protein-based group B Streptococcus vaccine.

Pawlowski et al
Cell Reports Medicine, 2022

A group B Streptococcus alpha-like protein subunit vaccine induces functionally active antibodies in humans targeting homotypic and heterotypic strains.

Fischer et al
Vaccine, 2021

Safety and immunogenicity of a prototype recombinant alpha-like protein subunit vaccine (GBS-NN) against Group B Streptococcus in a randomised placebo-controlled double-blind phase 1 trial in healthy adult women.